The energy balance in cancer cachexia revisited

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 6, 2014, Pages 509-514

  De Vos Geelen, Judith ^a   Fearon, Kenneth C H ^b   Schols, Annemie M W ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Anorexia; Brown adipose tissue; Cancer cachexia; Energy balance; Reward processing

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANOREXIA; BRAIN FUNCTION; BROWN ADIPOSE TISSUE; CACHEXIA; CANCER PATIENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENERGY BALANCE; HUMAN; NONHUMAN; REVIEW; REWARD; SATIETY; TUMOR MODEL; ANIMAL; BRAIN; COMPLICATION; DISEASE MODEL; ENERGY METABOLISM; NEOPLASM; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

ANIMALIA;

ADIPOSE TISSUE, BROWN; ANIMALS; BRAIN; CACHEXIA; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HUMANS; NEOPLASMS; NUTRITIONAL REQUIREMENTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84927800517     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000106     Document Type: Review

References (52)

1. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12:489-495.
2. Pausch T, Hartwig W, Hinz U, et al. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery 2012; 152 (Suppl 1):S81-S88.
3. Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31:1539-1547.
4. Wu J, Huang C, Xiao H, et al. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition 2013; 29:1310-1314.
5. Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, et al. Megestrol acetate for treatment of anorexia-cachexia syndrome [review]. Cochrane Libr 2013; 1-197.
6. Tuca A, Jimenez-Fonseca P, Gascón P. Clinical evaluation and optimal management of cancer cachexia. Crit Rev Oncol Hematol 2013; 88:625-636.
7. Redman LM, Heilbronn LK, Martin CK, et al. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One 2009; 4:e4377.
8. Plasqui G, Bonomi AG, Westerterp KR. Daily physical activity assessment with accelerometers: new insights and validation studies. Obes Rev 2013; 14:451-462.
9. Hasegawa M, Maeda H, Deng Z, et al. Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer. Int J Oncol 2014; 45:1017-1026.
10. Aupérin A, Le Péchoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010; 28:2181-2190.
11. Op den Kamp CH, De Ruysscher DM, van den Heuvel M, et al. Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer. J Cachexia Sarcopenia Muscle 2014; 5:127-137.
12. Vaisman N, Lusthaus M, Niv E, et al. Effect of tumor load on energy expenditure in patients with pancreatic cancer. Pancreas 2012; 41:230-232.
13. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012; 16:153-166.
14. Ravasco P, Monteiro-Grillo I, Camilo M. Colorectal cancer: intrinsic characteristics modulate cancer energy expenditure and the risk of cachexia. Cancer Invest 2007; 25:308-314.
15. Tsoli M, Schweiger M, Vanniasinghe AS, et al. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation. PLoS One 2014; 9:e92966.
16. Vosselman MJ, Brans B, van der Lans AA, et al. Brown adipose tissue activity after a high-calorie meal in humans. Am J Clin Nutr 2013; 98:57-64.
17. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Coldactivated brown adipose tissue in healthy men. N Engl J Med 2009; 360:1500-1508.
18. Pope M, Budge H, Symonds ME. The developmental transition of ovine adipose tissue through early life. Acta Physiol (Oxf) 2014; 210:20-30.
19. Wu J, Boström P, Sparks LM, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150:366-376.
20. Contreras C, Gonzalez F, Fernø J, et al. The brain and brown fat. Annals of Medicine 2014. [Epub ahead of print]
21. Elsen M, Raschke S, Eckel J. Browning of white fat: does irisin play a role in humans? J Endocrinol 2014; 222:R25-R38.
22. Choi HY, Kim S, Park JW, et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab 2014. [Epub ahead of print]
23. Hany TF, Gharehpapagh E, Kamel EM, et al. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002; 29:1393-1398.
24. Cohade C. Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect. Semin Nucl Med 2010; 40:283-293.
25. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360:1509-1517.
26. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009; 360:1518-1525.
27. Yoneshiro T, Aita S, Matsushita M, et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver Spring) 2011; 19:13-16.
28. Saito M, Okamatsu-Ogura Y, Matsushita M, et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009; 58:1526-1531.
29. Whittle A, Relat-Pardo J, Vidal-Puig A. Pharmacological strategies for targeting BAT thermogenesis. Trends Pharmacol Sci 2013; 34:347-355.
30. Ravussin E, Galgani JE. The implication of brown adipose tissue for humans. Annu Rev Nutr 2011; 31:33-47.
31. Nedergaard J, Bengtsson T, Cannon B. Three years with adult human brown adipose tissue. Ann N Y Acad Sci 2010; 1212:E20-36.
32. Tews D, Wabitsch M. Renaissance of brown adipose tissue. Horm Res Paediatr 2011; 75:231-239.
33. Tsoli M, Moore M, Burg D, et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer Res 2012; 72:4372-4382.
34. Roe S, Cooper AL, Morris ID, Rothwell NJ. Mechanisms of cachexia induced by T-cell leukemia in the rat. Metabolism 1996; 45:645-651.
35. Oudart H, Calgari C, AndriamampandryM, et al. Stimulation of brown adipose tissue activity in tumor-bearing rats. Can J Physiol Pharmacol 1995; 73:1625-1631.
36. Arruda AP, Milanski M, Romanatto T, et al. Hypothalamic actions of tumor necrosis factor alpha provide the thermogenic core for the wastage syndrome in cachexia. Endocrinology 2010; 151:683-694.
37. Edstrom S, Kindblom LG, Lindmark L, Lundholm K. Metabolic and morphologic changes in brown adipose tissue from nongrowing mice with an isogeneic sarcoma. Evaluation with respect to development of cachexia. Int J Cancer 1986; 37:753-760.
38. Tsoli M, Painter A, Berghofer P, et al. Activation of BAT in cancer cachexia/ anorexia syndrome: a maladaptive response to reduced food intake driven by tumour-derived IL-6. In: Pre-Congress Meeting On Brown Adipose Tissue And Human Obesity; 10-11 July 2010; Stockholm.
39. Ouellet V, Routhier-Labadie A, Bellemare W, et al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab 2011; 96:192-199.
40. Lee P, Greenfield JR, Ho KK, Fulham MJ. A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2010; 299:E601-E606.
41. Bianchi A, Bruce J, Cooper AL, et al. Increased brown adipose tissue activity in children with malignant disease. Horm Metab Res 1989; 21:640-641.
42. Huang YC, Chen TB, Hsu CC, et al. The relationship between brown adipose tissue activity and neoplastic status: an (18)F-FDG PET/CT study in the tropics. Lipids Health Dis 2011; 10:238.
43. Bauwens M, Wierts R, Royen B, et al. Molecular imaging of brown adipose tissue in health and disease. Eur J Nucl Med Mol Imaging 2014; 41:776-791.
44. Ouellet V, LabbéSM, Blondin DP, et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 2012; 122:545-552.
45. Balstad TR, Solheim TS, Strasser F, et al. Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review. Crit Rev Oncol Hematol 2014; 91:210-221.
46. Steinbach S, Hummel T, Böhner C, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 2009; 27:1899-1905.
47. Nicolini A, Ferrari P, Masoni MC, et al. Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment. Biomed Pharmacother 2013; 67:807-817.
48. Molfino A, Formiconi A, Fanelli FR, et al. Ghrelin: from discovery to cancer cachexia therapy. Curr Opin Clin Nutr Metab Care 2014. [Epub ahead of print]
49. Braun TP, Marks DL. Pathophysiology and treatment of inflammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle 2010; 1:135-145.
50. Frankort A, Roefs A, Siep N, et al. Reward activity in satiated overweight women is decreased during unbiased viewing but increased when imagining taste: an event-related fMRI study. Int J Obes 2012; 36:627-637.
51. Roefs A, Stapert D, Isabella LAS, et al. Early associations with food in anorexia nervosa patients and obese people assessed in the affective priming paradigm. Eat Behav 2005; 6:151-163.
52. Sánchez-Lara K, Arrieta O, Pasaye E, et al. Brain activity correlated with food preferences: A functional study comparing advanced non-small cell lung cancer patients with and without anorexia. Nutrition 2013; 29:1013-1019.